Valur Ragnarsson

Valur is a pharmaceutical executive with a solid track record spanning over 30 years. Valur is on the board of directors of Cori Pharma. He previously served as global CEO of Medis, a subsidiary of Teva Pharmaceuticals. His earlier positions include Executive Vice President, Third Party Sales, at Actavis Group as well as roles within Aventis (later Sanofi Aventis) and Lundbeck. He has served on the board of several pharmaceutical companies. Valur has an M.Sc. Pharmacy degree from the University of Iceland.